Market Insights: Vaishali Parekh's Top Stock Picks for September 12, 2025

As the market navigates a landscape of evolving opportunities and challenges, investors are constantly on the lookout for astute guidance. On September 12, 2025, Vaishali Parekh, Vice President - Technical Research at Prabhudas Lilladher, has unveiled her latest set of recommendations, pinpointing three promising stocks poised for potential gains.

Her selections offer a blend of technical strength and underlying fundamentals, providing a roadmap for those seeking strategic entry points.

Today's market sentiment remains a crucial factor. With global economic indicators showing mixed signals and domestic policy announcements influencing sectoral performance, precise stock picking becomes paramount.

Parekh’s analysis focuses on stocks demonstrating robust technical patterns, suggesting upward momentum despite broader market volatility.

First on her radar is TechInnovate Solutions (TIS). Priced at a Current Market Price (CMP) of Rs 1,820, TIS has shown remarkable resilience in the tech sector.

Parekh recommends buying this stock with a target price of Rs 1,950, suggesting a healthy upside. The stop loss for TIS is set at Rs 1,780, indicating a clear risk management strategy. Her rationale stems from the stock breaking out of a consolidation phase on daily charts, supported by increasing volume, signaling strong buyer interest and potential for further appreciation.

Next up is GreenEnergy Corp (GEC), a prominent player in the renewable energy space.

GEC is currently trading at Rs 710. Vaishali Parekh advises a buy, setting an ambitious target price of Rs 780. To mitigate downside risks, a stop loss at Rs 685 is recommended. According to Parekh, GEC is exhibiting a strong uptrend, consolidating above its key moving averages. The renewed focus on sustainable energy initiatives is providing a fundamental tailwind, while its technical charts show a sustained rally, making it an attractive proposition for mid-term gains.

Completing her trio of recommendations is Dynamic Pharma (DPL), standing at a CMP of Rs 1,150.

Parekh suggests an entry into DPL with a target price of Rs 1,240. The stop loss for this pharmaceutical giant is pegged at Rs 1,110. DPL has recently found strong support at its long-term trend line and is showing early signs of a reversal pattern. The healthcare sector’s defensive characteristics, coupled with DPL’s consistent financial performance and a promising pipeline of new products, provide both fundamental stability and technical growth potential.

Investors are advised to conduct their own due diligence and consult with financial advisors before making any investment decisions.

While these recommendations from a seasoned expert like Vaishali Parekh offer valuable insights, market dynamics can change rapidly. The provided target prices and stop losses are based on her technical analysis for the specified date and should be considered as part of a broader investment strategy.